|
Année 2009 |
|
|
Hepatic resection for inflammatory hepatocellular adenomas: pathological identification of micro-nodules expressing inflammatory proteins
Bioulac-Sage P*, Laumonier H, Cubel G, Zucman-Rossi J, Balabaud C.
Liver international, 2009, 2(3):316-21.
The ATPase Pontin is overexpressed in hepatocellular carcinoma and co-regulated with Reptin through a new post-translational mechanism.
Haurie V, Ménard L, Nicou A, Touriol C, Metzler P, Fernandez J, Taras D, Lestienne P, Balabaud C, Bioulac-Sage P, Prats H, Zucman-Rossi J, Rosenbaum J*.
Hepatology, 2009, 67(1):23-30.
Micro-ARNs (miARNs) et cancer : le cas des tumeurs hépatocellulaires.
Ladeiro Y, Zucman-Rossi J.
Medecine Sciences, 25(5):467-72, 2009. Revue sur invitation.
p16INK4A inactivation mechanisms in non small-cell lung 1 cancer patients occupationally exposed to asbestos.
Andujar P, Wang J, Descatha A, Galateau-Sallé F, Abd-Alsamad I, Billon-Galland MA, Blons H, Clin-Godard B, Danel C, Housset B, Laurent-Puig P, Le Pimpec-Barthes F, Letourneux M, Monnet I, Régnards JF, Renier A, Zucman-Rossi J, Pairon JC, Jaurand MA*.
Lung Cancer, in press, 2009.
Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience
Bioulac-Sage P*, Laumonier H, Couchy G, Le Bail B, Sa Cunha A, Rullier A, Laurent C, Blanc J-F, Cubel G, Trillaud H, Zucman-Rossi J, Balabaud C, Saric J.
Hepatology, In press, 2009.
Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology..
Bioulac-Sage P, Laumonier H, Rullier A, Cubel G, Laurent C, Zucman-Rossi J, Balabaud C.
Liver Int. 2009 Mar;29(3):459-65.
Management of hepatocellular carcinoma. Where are we now? What's next?
Taieb J, Barbare JC, Boussaha T, Cunha AS, Baere T, Rosmorduc O, Zucman-Rossi J, Franco D.
Bull Cancer. 2009 Feb;96(1):19-34.
Fundamental and translational research on hepatocellular carcinoma in 2008: forces and priorities
Zucman-Rossi J, Clément B, Buendia MA, Lerat H, Beers BV, Bedossa P, Taieb J, Rosenbaum J.
Bull Cancer. 2009 Feb;96(1):45-50.
Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours.
Rebouissou S, Amessou M, Couchy G, Poussin K, Imbeaud S, Pilati C, Izard T, Balabaud C, Bioulac-Sage P, Zucman-Rossi J.
Nature. 2009 Jan 8;457(7226):200-4.
|
|
|
|
Année 2008 |
|
|
Gp130-activating mutations in inflammatory liver adenomas
Zucman-Rossi J, Amessou M, Bioulac-Sage P, Rebouissou S.
Med Sci (Paris). 2008 Dec;24(12):1113-4.
Hepatocellular adenomas: MRI features as a function of molecular
pathological classification
Laumonier H*, Bioulac-Sage P, Laurent C, Zucman-Rossi J, Balabaud C,
Trillaud H.
Hepatology. 2008 Sep;48(3):808-18.
The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules
Rebouissou S, Couchy G, Libbrecht L, Balabaud C, Imbeaud S, Auffray C,
Roskams T, Bioulac-Sage P, Zucman-Rossi J.
J Hepatol. 2008 Jul;49(1):61-71
MicroRNA profiling in hepatocellular tumors is associated
to clinical features and oncogene/tumor suppressor gene mutations.
Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, Rebouissou S, Zucman-Rossi J.
Hepatology, 2008, 47, 6, 1955-1963
Hepatocellular adenoma : what is new in 2008
Bioulac-Sage P, Laumonier H, Laurent H, Zucman-Rossi J, Balabaud C.
Hepatology International, In press, 2008.
Les tumeurs hépatocytaires bénignes. Des connaissances récentes : de la biologie moléculaire au diagnostic.
Bioulac-Sage* P, Balabaud C, Zucman-Rossi J.
Gastroenterol Clin Biol, 32(3):296-303, 2008.
Human and mouse hepatocellular adenoma and carcinoma
display similar tumorigenesis pathway alterations
Zucman-Rossi J.
J Hepatol, 48(5):884-6, 2008
|
|
|
|
Année 2007 |
|
|
Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma.
Rebouissou S, Bioulac-Sage P, Zucman-Rossi J.
J Hepatol, 2008, 48(1):163-170.
Loss of the tripartite motif-containing gene Trim24 (Tif1a) confers oncogenic activity to retinoic acid receptor alpha.
Khetchoumian K, Teletin M, Tisserand J, Mark M, Herquel B, Ignat M, Zucman-Rossi J, Cammas F, Lerouge T, Thibault C, Metzger D, Chambon P, Losson R.
Nature Genet, 39(12):1500-6.
The genetic diversity of hepatocellular carcinomas and its potential impact on targeted therapies.
Zucman-Rossi J, Laurent-Puig P.
Pharmacogenomics, 2007, 8:997-1003.
Regressive liver adenomatosis following androgenic progestin therapy withdrawal: a case report with a 10-year follow-up and a molecular analysis.
Svrcek M, Jeannot E, Arrive L, Poupon R, Fromont G, Flejou JF, Zucman-Rossi J, Bouchard P, Wendum D.
Eur J Endocrinol. 2007, 156:617-62.
Genotype phenotype classification of hepatocellular adenoma.
Bioulac-Sage P, Blanc JF, Rebouissou S, Balabaud C, Zucman-Rossi J.
WJG, 21:2649-54.
Overexpression and role of RUVBL2 in human hepatocellular carcinoma.
Rousseau B*, Ménard L*, Haurie V, Taras D, Blanc JF, Moreau-Gaudry F, Metzler P, Hugues M, Boyault S, Lemière S, Canron X, Costet P, Cole M, Balabaud C, Bioulac-Sage P, Zucman-Rossi J, Rosenbaum J.
Hepatology, 2007, 46:1108-1118.
HNF1a inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and ChREBP activation
Rebouissou S, Imbeaud S, Balabaud C, Boulanger V, Bertrand-Michel J, Tercé F, Auffray C, Bioulac-Sage P, Zucman-Rossi J.
JBC, 2007, 282: 14437-46.
Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry.
Bioulac-Sage P*, Rebouissou S*, Thomas C, Blanc JF, Saric J, Sa Cunha A, Rullier A, Cubel G, Couchy G, Imbeaud S, Balabaud C, Zucman-Rossi J.
Hepatology, 2007, 46:740-8.
*equally contributed.
Association of CYP1B1 germline mutations with HNF1a mutated hepatocellular adenoma
Jeannot E, Poussin K, Chiche L, Bacq Y, Sturm N, Scoazec J-Y, Buffet C, Tran Van Nhieu J, Bellanné-Chantelot C, de Toma C, Laurent-Puig P, Bioulac-Sage P, Zucman-Rossi J.
Cancer Research, 2007, 67: 2611-2616
Inflammatory syndrome revealing liver adenomatosis: the beneficial effects of surgical management
Sa Cunha A, Blanc JF, Lazaro E, Mellottee L, Le Bail B, J Zucman-Rossi, Balabaud C, Bioulac-Sage P.
Gut, 2007, 56: 307-309
Differential effects of inactivated Axin1 and activated ß-catenin mutations in human hepatocellular carcinomas
Zucman-Rossi J, Benhamouche S, Godard C, Boyault S, Grimber G, Balabaud C, Sa Cunha A, Bioulac-Sage P, Perret C.
Oncogene, 2007, 26(5):774-80
Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update
P Bioulac-Sage, C Balabaud, P Bedossa, JY Scoazec, L Chiche, AP Dhillon, L Ferrell, V Paradis T Roskams, V Vilgrain, IR Wanless, J Zucman-Rossi and members of the Laennec and Elves group.
J Hepatol, 2007, 46: 521-527
Transcriptome classification of HCC is related to gene mutations and new therapeutic targets
S Boyault, DS Rickman, A de Reyniès, C Balabaud, S Rebouissou, E Jeannot, A Hérault, J Saric, J Belghiti, D Franco, P Bioulac-Sage, P Laurent-Puig, J Zucman-Rossi.
Hepatology, 2007, 45:42-52
|
|
|
|
Année 2006 |
|
|
Hepatocellular adenoma displaying a HNF1a inactivation in a patient with familial adenomatous polyposis coli
Jeannot E, Wendum D, Paye F, Mourra N, de Toma C, Fléjou JF, Zucman-Rossi J.
J Hepatol, 2006, 45:883-6, see editorial
Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC
Zucman-Rossi J, Jeannot E, Tran Van Nhieu J, Jean-Yves Scoazec JY, Guettier C, Rebouissou S, Bacq Y. Leteurtre E, Paradis V, Michalak S, Wendum D, Chiche L, Fabre M, Mellottee L, Laurent C, Partensky C, Castaing D, Zafrani ES, Laurent-Puig P, Balabaud C, Bioulac-Sage P.
Hepatology. 2006, 43(3):515-524 see editorial p401.
Genetics of hepatocellular tumors
Laurent-Puig P, Zucman-Rossi J.
Oncogene, 2006 25, 3778-3786
Different carcinogenetic pathways to HCC
Zucman-Rossi J.
Advances in Gastrointestinal Cancer, 4 : 7-10, 2006
|
|
|
|
Année 2005 |
|
|
Clinical, Morphological and molecular features defining telangiectatic focal nodular hyperplasias of the liver
Bioulac-Sage P, Rebouissou S, Sa Cunha A, Jeannot E, Lepreux S, Blanc
JF, Blanché H, le Bail B, Saric J, Laurent-Puig P, Balabaud C,
Zucman-Rossi J.
Gastroenterology, 2005 ;128:1211-8
Germline Hepatocyte Nuclear Factor 1α and 1ß mutations in renal cell carcinomas
Rebouissou S, Vasiliu V, Thomas C, Bellanné-Chantelot C, Bui H,
Chrétien Y, Timsit J, Rosty C, Laurent-Puig P, Chauveau D, Zucman-Rossi
J.
Human Molecular Genetics, 2005;14(5):603-14
Absence of KLF6 gene mutation in 71 hepatocellular carcinomas
Boyault S, Herault A, Balabaud C, Zucman-Rossi J.
Hepatology, 2005;41(3):681-2.
Mutation of TP53 gene is involved in carcinogenesis of hepatic
undifferentiated (embryonal) sarcoma of the adult, in contrast with Wnt
or telomerase pathways: an immunohistochemical study of three cases
with genomic relation in one case
Lepreux S, Rebouissou S, Le Bail B, Saric J, Balabaud C, Bloch B, Martin-Négrier ML, Zucman-Rossi J, Bioulac-Sage P
J hepatol, 2005;42(3):424-9 |
|
|
|
Année 2004 |
|
|
Mutation of TCF1 encoding hepatocyte nuclear factor 1alpha in gynecological cancer
Rebouissou S, Rosty C, Lecuru F, Boisselier S, Bui H, Lefrere-Belda MA, Sastre X, Laurent-Puig P, Zucman-Rossi J.
Oncogene. 2004
Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas
Cazals-Hatem D, Rebouissou S, Bioulac-Sage P, Bluteau O, Blanche H,
Franco D, Monges G, Belghiti J, Sa Cunha A, Laurent-Puig P, Degott C,
Zucman-Rossi J
J Hepatol. 2004;41(2):292-8
Hepatocyte
nuclear factor-1 alpha gene inactivation: cosegregation between liver
adenomatosis and diabetes phenotypes in two maturity-onset diabetes of
the young (MODY)3 families
Reznik Y, Dao T, Coutant R,
Chiche L, Jeannot E, Clauin S, Rousselot P, Fabre M, Oberti F, Fatome
A, Zucman-Rossi J, Bellanne-Chantelot C.
J Clin Endocrinol Metab. 2004;89(3):1476-80
|
|
|
|
Année 2003 |
|
|
Familial liver adenomatosis associated with Hepatocyte Nuclear Factor 1 alpha inactivation
Bacq T, Jacquemin E, Balabaud C, Jeannot E, Scotto B, Branchereau S,
Laurent C, Bourlier P, Pariente D, De Muret A, Fabre M, Bioulac-Sage P,
Zucman-Rossi J.
Gastroenterology 2003; 125:1470-5.
The identification of small nodules in liver adenomatosis
Lepreux S, Laurent C, Blanc JF, Trillaud H, Le Bail B, Trouette H, Saric J, Zucman-Rossi J, Balabaud C, Bioulac-Sage P.
J Hepatol, 2003 Jul;39(1):77-85
Frequent mutations of hepatocyte nuclear factor 1 in colorectal cancer with microsatellite instability
Laurent-Puig P, Plomteux O, Bluteau O, Zinzindohoue F, Jeannot E, Dahan K, Kartheuser A, Chapusot C, Cugnenc PH, Zucman-Rossi J.
Gastroenterology 124:1311-4, 2003
|
|
|
|
Années 2002 et antérieures |
|
|
Bi-allelic inactivation of TCF1 in hepatic adenomas.
Bluteau O, Jeannot E, Bioulac-Sage P, Marques JM, Blanc JF, Bui H,
Beaudoin JC, Franco D, Balabaud C, Laurent-Puig P, Zucman-Rossi J.
Nature Genet, 2002
Specific
association between alcohol intake, high grade of differentiation and
4q34-q35 deletions in hepatocellular carcinomas identified by high
resolution allelotyping.
Bluteau O, Beaudoin JC, Pasturaud P, Belghiti J, Franco D, Bioulac-Sage P, Laurent-Puig P, Zucman-Rossi J.
Oncogene 21:1225-1232, 2002
Identification of homozygous deletions at chromosome 16q23 in aflatoxin B1 exposed hepatocellular carcinoma.
Yakicier MC, Legoix P, Vaury C, Gressin L, Tubacher E, Capron F, Bayer J, Degott C, Balabaud C, Zucman-Rossi J.
Oncogene 20:5232-5238, 2001
Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis
Laurent-Puig P, Legoix P, Bluteau O, Belghiti J, Franco D, Binot F, Monges G, Thomas G, Bioulac-Sage P, Zucman-Rossi J.
Gastroenterology 120:1763-1773, 2001
|
|
|
|
Les publications récentes 
